Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/1996
08/27/1996US5549674 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo
08/27/1996CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
08/27/1996CA2046345C Functional food
08/27/1996CA1338551C Medicament for thrombotic disorder containing t-pa
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025520A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996WO1996025519A1 Virulence-attenuating genetic deletions
08/22/1996WO1996025511A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
08/22/1996WO1996025508A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025501A2 Method and composition for regulating apoptosis
08/22/1996WO1996025499A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996WO1996025498A2 Mpl ligand analogs
08/22/1996WO1996025497A1 New chemokines expressed in pancreas
08/22/1996WO1996025496A1 PRODUCTION OF BIOLOGICALLY ACTIVE RECOMBINANT BOVINE FOLLICLE STIMULATING HORMONE (REC bFSH) IN THE BACULOVIRUS EXPRESSION SYSTEM
08/22/1996WO1996025495A1 Sperm factor
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025493A1 Multiple-tumor aberrant growth genes
08/22/1996WO1996025492A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS
08/22/1996WO1996025491A2 Inhibition of proliferation of vascular smooth muscle cell
08/22/1996WO1996025488A1 A constitutively active phosphatidylinositol 3-kinase and uses thereof
08/22/1996WO1996025487A1 Materials and methods relating to the regulation of polypeptide production in cells
08/22/1996WO1996025435A1 MONOCLONAL ANTIBODY SPECIFIC FOR βA4 PEPTIDE
08/22/1996WO1996025434A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
08/22/1996WO1996025433A1 B cell differentiation and proliferation factors and methods for obtaining and using the same
08/22/1996WO1996025432A1 Human g-protein coupled receptor
08/22/1996WO1996025428A1 Novel nk374186 analogues or pharmacologically acceptable salts thereof
08/22/1996WO1996025427A1 Serine protease inhibitors
08/22/1996WO1996025426A1 Novel dipeptide amidines as thrombin inhibitors
08/22/1996WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025184A1 Treatment of vascular thrombosis and restenosis with inhaled nitric oxide
08/22/1996WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY
08/22/1996WO1996025175A1 ADMINISTRATION OF A CYCLOSPORINE-SPECIFIC MONOCLONAL ANTIBODY THAT CROSS-REACTS WITH HIV-1 p24 GAG TO TREAT HIV INFECTION
08/22/1996WO1996025174A1 Muscle protein decomposition inhibitor containing il-6 receptor antibody
08/22/1996WO1996025171A1 Inhibition of angiogenesis using interleukin-12
08/22/1996WO1996025170A1 METHOD FOR TREATMENT OF DISEASE WITH ANTI-SIGMA FACTOR AsiA
08/22/1996WO1996025155A1 Diagnosis of and compositions and methods for the treatment of disease
08/22/1996WO1996017935A3 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
08/22/1996DE19605657A1 Proinsulinderivat und Verfahren zur Herstellung von menschlichem Insulin Proinsulin derivative and process for the preparation of human insulin
08/22/1996DE19504776A1 Thrombin-inhibiting protein
08/22/1996CA2223125A1 Production of biologically active recombinant bovine follicle stimulating hormone (recbfsh) in the baculovirus expression system
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213237A1 Multiple-tumor aberrant growth genes
08/22/1996CA2213233A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996CA2213229A1 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
08/22/1996CA2213132A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
08/22/1996CA2212830A1 Serine protease inhibitors
08/22/1996CA2212370A1 Inhibition of angiogenesis using interleukin-12
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2211162A1 Nucleic acid-containing composition, preparation and use thereof
08/22/1996CA2211109A1 Novel thrombin inhibitors
08/22/1996CA2211101A1 Materials and methods relating to the regulation of polypeptide production in cells
08/22/1996CA2210538A1 Eukaryotic initiation factor 5a (eif-5a) mutants
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/22/1996CA2209227A1 New chemokines expressed in pancreas
08/22/1996CA2188462A1 Method and composition for regulating apoptosis
08/21/1996EP0727490A1 Human-origin prostacyclin synthase
08/21/1996EP0727487A1 Multiple-tumor aberrant growth genes
08/21/1996EP0727486A2 Tumour suppressor gene
08/21/1996EP0727438A2 Adducts of PEG and GM-CSF
08/21/1996EP0727437A2 Covalent PEG-protein adducts
08/21/1996EP0727436A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0727435A1 Monoclonal antibodies against tumor associated antigen, their preparation and use
08/21/1996EP0727419A2 Retroviral protease inhibiting compounds
08/21/1996EP0726956A1 Novel human transglutaminases
08/21/1996EP0726954A1 Cntf family antagonists
08/21/1996EP0726953A1 Human kunitz-type protease inhibitors
08/21/1996EP0726952A1 Receptor on the surface of activated t-cells:acts-4
08/21/1996EP0726949A1 Opioid receptor: compositions and methods
08/21/1996EP0726948A1 Method of inducing and maintaining neuronal cells
08/21/1996EP0726945A1 B1k CHAIN OF LAMININ AND METHODS OF USE
08/21/1996EP0726944A1 Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
08/21/1996EP0726943A1 Activated factor xiii
08/21/1996EP0726942A1 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use
08/21/1996EP0726941A1 METHODS FOR $i(EX VIVO) THERAPY USING PEPTIDE-LOADED ANTIGEN PRESENTING CELLS FOR THE ACTIVATION OF CTL
08/21/1996EP0726914A1 Cell surface protein expressed on human cortical thymocyte and their use
08/21/1996EP0726913A1 Cytokines from natural killer or t cells
08/21/1996EP0726912A1 Cd6 ligand
08/21/1996EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726907A1 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods
08/21/1996EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications
08/21/1996EP0726780A1 Treatment for rheumatoid arthritis
08/21/1996EP0726779A1 Methods of stimulating phagocytosis
08/21/1996EP0726778A1 Oral delivery of chemically modified proteins
08/21/1996EP0726777A1 Prokaryotic expression of mhc proteins
08/21/1996EP0726776A1 Inhibition of hiv mucosal infection
08/21/1996EP0726773A1 Method for inhibiting angiogenesis using heparinase
08/21/1996EP0726772A1 A method for sensitization of cancer cells for killer cell mediated lysis
08/21/1996EP0726771A1 Desferrioxamine oral delivery system
08/21/1996EP0726770A1 Sulfamethoxazole-specific immunosuppressive agents
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0726767A1 Biochemically active agents for chemical catalysis and cell receptor activation
08/21/1996EP0726766A1 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
08/21/1996EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/21/1996EP0726741A1 Implant assembly
08/21/1996EP0700303A4 Enteral nutritional product
08/21/1996EP0695307A4 Modified protein and peptide pharmaceuticals
08/21/1996EP0660723B1 Vp6 encapsulated drug delivery
1 ... 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 ... 3163